B
BNTX
BIONTECH
110.15
-0.28-0.25%After Hours: 110.18 +0.04 +0.03%18:58 02/20 EST
OPEN/PREV CLOSE109.19/110.42
TODAY RANGE108.65-110.89
VOL946.24K
MARKET CAP28.53B
52 WEEK RANGE81.20-124.49
AVG VOL (3M)1.12M
% TURNOVER0.37%
TURNOVER--
P/E (TTM)-39.7908
% RANGE1.95%
EPS(TTM)-2.7681
P/E(FORWARD)-27.3353
P/B1.220
BVPS90.28
DIVIDEND--
P/S9.23
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP12.33B
SHARES OUTSTANDING259.03M
NEXT EARNINGS--
FREE FLOAT111.98M
LOT SIZE1
EX-DATE06/02/2022
News
Press Releases
Financial Reports
Profile
Seeking Alpha·1d ago
Moderna sued for violating patent linked to Pfizer/ BioNTech COVID-19 shot
Simply Wall St·2d ago
FDA Fast Track Win And New HR Chief Might Change The Case For Investing In BioNTech (BNTX)
TipRanks·4d ago
Morgan Stanley Keeps Their Buy Rating on BioNTech SE (BNTX)
Seeking Alpha·6d ago
Changes to U.S. vaccine policy under RFK Jr. challenged in court
TipRanks·02/09 13:46
Morgan Stanley Sticks to Their Buy Rating for BioNTech SE (BNTX)
Simply Wall St·02/07 20:05
Is BioNTech (BNTX) Pricing Reflecting Its Mixed Returns And Conflicting Valuation Signals?
Simply Wall St·02/06 19:18
BioNTech Hire Signals People Focus As Oncology Plans And Valuation Attract Attention
TipRanks·02/04 16:31
Pfizer and BioNTech Pause modRNA Shingles Ambitions
Simply Wall St·02/03 19:27
BioNTech Adds Chief People Officer To Support Oncology Growth Plans
TipRanks·02/02 14:51
Palantir upgraded, Best Buy downgraded: Wall Street’s top analyst calls
TipRanks·02/02 13:57
BioNTech SE (BNTX) Gets a Buy from Morgan Stanley
Simply Wall St·02/02 13:15
Assessing BioNTech (BNTX) Valuation After Goldman Sachs Buy Upgrade And Oncology Growth Focus
Same Industry
Name/Symbol
Change%
Price